MENDOLARO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 157
AS - Asia 68
EU - Europa 56
AF - Africa 19
SA - Sud America 9
Totale 309
Nazione #
US - Stati Uniti d'America 154
SG - Singapore 41
CN - Cina 23
IT - Italia 21
IE - Irlanda 18
CI - Costa d'Avorio 12
BR - Brasile 9
DE - Germania 9
SN - Senegal 7
CA - Canada 3
RU - Federazione Russa 3
GB - Regno Unito 2
UZ - Uzbekistan 2
BE - Belgio 1
IL - Israele 1
IN - India 1
PL - Polonia 1
UA - Ucraina 1
Totale 309
Città #
Santa Clara 37
Chandler 29
Singapore 22
Dublin 18
Abidjan 12
Chicago 12
Boardman 7
Civitanova Marche 7
Dakar 7
Catania 6
Council Bluffs 6
Andover 5
Bremen 5
Cambridge 5
Des Moines 5
Lawrence 5
The Dalles 5
Ashburn 4
Jacksonville 4
Grafing 3
Nanchang 2
Nanjing 2
Norwalk 2
Shenyang 2
Tappahannock 2
Tianjin 2
Toronto 2
Barra Mansa 1
Bauru 1
Beijing 1
Brussels 1
Civitavecchia 1
Gravataí 1
Guangzhou 1
Guaíba 1
Guiyang 1
Itu 1
Jiaxing 1
Krasnodar 1
Milan 1
Montes Claros 1
Nanning 1
Ningbo 1
Ottawa 1
Piripiri 1
São José do Rio Preto 1
Tel Aviv 1
Volta Redonda 1
Warsaw 1
Wilmington 1
Totale 241
Nome #
CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS (CMV) INFECTION IN INFLAMMATORY BOWEL DISEASE 76
EVALUATION OF CROHN’S DISEASE ACTIVITY BY DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING (MRI) 72
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis 64
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 58
P.01.15 EVALUATION OF CROHN'S DISEASE ACTIVITY BY DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING (MRI) 56
Totale 326
Categoria #
all - tutte 1.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 1 5
2020/202120 2 0 1 0 5 0 4 0 3 4 1 0
2021/202232 2 5 0 0 5 1 7 1 0 0 2 9
2022/202382 5 7 3 12 7 13 0 15 17 0 3 0
2023/202434 2 9 1 0 1 8 0 1 0 1 9 2
2024/2025131 3 16 8 14 32 18 7 7 16 5 5 0
Totale 326